Maria Vittoria Di Marco, M.S.
Maria Vittoria joined the Hata Lab in October 2024 as a visiting Ph.D. student from Roberto Chiarle’s lab at the University of Torino. In Torino, her research focused on identifying new therapeutic strategies for lung cancers harboring the EML4-ALK fusion gene that have become resistant to ALK-specific tyrosine kinase inhibitors. She worked on generating in vitro and in vivo models of TKI-resistant ALK+ NSCLCs to test the synergy between small molecule inhibitors of nuclear export and second- and third-generation ALK inhibitors, aiming to overcome resistance and prevent tumor recurrence. At the Hata Lab, Maria Vittoria is interested in delving deeper into the genomic instability that drives acquired drug resistance and promotes the evolution of drug-tolerant persister cells (DTPs) in both EGFR-mutated and ALK-rearranged NSCLC. Outside of the lab, she enjoys exploring the Italian -now American- countryside, reading, and baking.